Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 6,066,000 | 7,211,000 | 4,969,000 | 4,354,000 | 1,937,000 |
| Cost of Goods | 1,017,000 | 952,000 | 722,000 | 750,000 | 193,000 |
| Gross Profit | 5,049,000 | 6,259,000 | 4,247,000 | 3,604,000 | 1,744,000 |
| Operating Expenses | 822,000 | 849,000 | 689,000 | 542,000 | 478,000 |
| Operating Income | 4,227,000 | 5,410,000 | 3,558,000 | 3,062,000 | 1,266,000 |
| Other Income | 2,000 | 0 | -6,000 | 1,000 | -6,000 |
| Pre-tax Income | 4,229,000 | 5,410,000 | 3,552,000 | 3,063,000 | 1,260,000 |
| Income Tax | 572,000 | 542,000 | 219,000 | 283,000 | 39,000 |
| Net Income Continuous | 3,657,000 | 4,868,000 | 3,333,000 | 2,780,000 | 1,221,000 |
| Net Income | $3,657,000 | $4,868,000 | $3,333,000 | $2,780,000 | $1,221,000 |
| EPS Basic Total Ops | 9.09 | 12.06 | 8.27 | 6.93 | 3.05 |
| EPS Basic Continuous Ops | 9.10 | 12.06 | 8.25 | 6.92 | 3.05 |
| EPS Diluted Total Ops | 8.58 | 11.29 | 7.70 | 6.46 | 2.84 |
| EPS Diluted Continuous Ops | 8.58 | 11.34 | 7.68 | 6.45 | 2.84 |
| EBITDA(a) | $4,324,000 | $5,509,000 | $3,648,000 | $3,139,000 | $1,286,000 |